1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. GYRE THERAPEUTICS INC
Gyre Therapeutics Inc XNAS: GYRE

Gyre Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-sta...

Read More
7.74 -0.54 (-6.52%)
59.26% Fall from 52W High
76,302
XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Expensive Valuation
27.5 / 100
Momentum Score
Technically Neutral
45.5 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
19
1Yr Price target upside is 145%
2 analysts

4

S

12

W

5

O

0

T

SWOT Analysis

Gyre Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..